• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Submit for the Fierce Pharma Marketing Awards - Deadline ends this Friday, July 3rd

Padcev

Astellas
Pharma

Inside Astellas CEO's plan to counter Xtandi's patent cliff

“It is not simply the cost optimization, but the way we do our business,” Astellas CEO Naoki Okamura explained to Fierce.
Angus Liu Jun 11, 2026 6:00pm
Volga River

AZ’s Imfinzi gains ground on Keytruda in bladder cancer race

May 14, 2026 11:52am
Pfizer

Pfizer's COVID franchise keeps guidance level after strong Q1

May 5, 2026 11:17am
Astellas

Astellas projects Xtandi decline but overall growth in FY2026

Apr 27, 2026 11:30am
Asia

Kyowa, Sino Biopharm, Duality—Fierce Pharma Asia

Mar 6, 2026 9:35am
Combine

Padcev-Keytruda combo wins in MIBC amid evolving landscape

Feb 27, 2026 10:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings